SOTU Debrief: ID Docs Critical for Biden's 2023 Health Priorities

 

Physicians who specialize in infectious diseases are an essential part of President Biden’s vision for seeking cancer cures and beating the opioid epidemic.

Infections are a frequent complication in cancer care, contributing to about half of all cancer deaths. ID physicians are critical members of a patient’s cancer care team, especially with the rise of antimicrobial-resistant superbugs among this vulnerable population.

The devastating effects of the opioid epidemic go beyond the tragic deaths of so many Americans. Opioid use has fueled increases in viral hepatitis, HIV, and skin and joint infections. People who inject drugs are 16 times more likely to contract MRSA, a deadly superbug. ID physicians are on the front lines of this fight and will remain until this battle is won.

President Biden reaffirmed his commitment to addressing these monumental health care challenges. Now his Administration and the new Congress must live up to promises made and invest in the infectious diseases workforce, support strategies to decrease antimicrobial resistance and fuel development of novel antibiotics. Reducing cancer and opioid deaths will only be possible with a strong infectious diseases workforce coupled with federal investments.

• Carlos del Rio, MD, FIDSA – President, Infectious Diseases Society of America

About IDSA
The Infectious Diseases Society of America is a community of more than 12,000 physicians, scientists and public health experts who specialize in infectious diseases. Its purpose is to improve the health of individuals, communities and society by promoting excellence in patient care, education, research, public health and prevention relating to infectious diseases. Learn more at idsociety.org.